Evidence map›Paper›PMID 25621100›Full record

ArticleCartilage2015

Management of Osteoarthritis with Avocado/Soybean Unsaponifiables.

Blaine A Christiansen, Simi Bhatti, Ramin Goudarzi, Shahin Emami

Erratum issued Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Cartilage, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05306314 (A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05306314 unknown statusnot on this mapstarted 2022, after this paper: background citation

A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis (Category II), Chronic Pelvic Pain (Category IIIA, IIIB)Treataprost Added to Standard Antibiotic Treatment in Real-life Clinical Practice

TypeobservationalSponsorGMG Grand MedicalRan2022 to 2023Enrolled140ConditionsQuality of Life, Infection, Bacterial, PSA, ProstatitisArmsTREATAPROST
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Anti-Aging Potential of Avocado Oil via Its Antioxidant Effects.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Temporomandibular Myofascial Pain Syndrome-Aetiology and Biopsychosocial Modulation. A Narrative Review.International journal of environmental research and public health · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Blaine A ChristiansenUniversity of California-Davis Health System, Department of Orthopaedic Surgery, Lawrence J. Ellison Musculoskeletal Research Center, 4635 2nd Ave, Suite 2000, Sacramento, CA 95817, .
Simi BhattiFormulation Technology Inc. 571 Armstrong Way Oakdale, CA 95361 Ph: 209- 847-0331.
Ramin GoudarziPharmin USA, LLC, 2375 Lindbergh Avenue San Jose, CA 95128 .
Shahin EmamiCorresponding author: shahin.emami1@gmail.com.
Film Independent · USUC Davis Health · US

Funding

The role of the inflammatory response in bone and cartilage changes following nonK01AR062603 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHRISTIANSEN, BLAINE A. · 2012 to 2016
$569k
NIAMS NIH HHS K01 AR062603
6 · The paper itself

Abstract

Osteoarthritis (OA) is a painful and life-altering disease that severely limits the daily activity of millions of Americans, and is one of the most common causes of disability in the world. With obesity on the rise and the world's population living longer, the prevalence of OA is expected to increase dramatically in the coming decades, generating burdensome socioeconomic costs. This review summarizes current pharmaceutical, non-pharmaceutical, and prospective new treatments for OA, with primary focus on the dietary supplement Avocado/Soybean Unsaponifiables (ASU). ASU modulates OA pathogenesis by inhibiting a number of molecules and pathways implicated in OA. Anticatabolic properties prevent cartilage degradation by inhibiting the release and activity of matrix metalloproteinases (MMP-2,3,13) and increasing tissue inhibitors of these catabolic enzymes (TIMP-1). ASU also inhibits fibrinolysis by stimulating the expression of plasminogen activator inhibitor (PAI-1). Anabolic properties promote cartilage repair by stimulating collagen and aggrecan synthesis via inhibition of inflammatory cytokines such as IL1, IL6, IL8, TNF, ERK, and PGE2. Chondroprotective effects are mediated by correcting growth factor abnormalities, increasing TGFβ while decreasing vascular endothelial growth factor (VEGF) in synovial fluid. ASU also inhibits cholesterol absorption and endogenous cholesterol biosynthesis, which mediate reactive oxygen species pathology in chondrocytes. At the clinical level, ASU reduces pain and stiffness while improving joint function, resulting in decreased dependence on analgesics.

Indexed as

Arthrocenavocado soybean unsaponifiables (ASU)cartilagedietary supplementsOsteoarthritis

Identifiers

PMID25621100
PMCPMC4303902
OpenAlexW2137356528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.